The BHC’s Pharmacy Management Initiative (PMI) is a PBM purchasing coalition which brings together forward-thinking employers to leverage collective purchasing power, secure best-in-class PBM contracts, and drive meaningful cost savings. Participating organizations receive a favorable contract; annual market checks, audits, and price improvements; cost-effective clinical programs; data benchmarking; and bi-monthly educational events. Currently contracting with CVS Health and Express Scripts, the program supports nearly 50 employers representing over 300,000 lives nationally.

We are a diversified health services company with more than 300,000 employees united around a common purpose of bringing our heart to every moment of your health. Our mission at CVS Health is to take on many of the country’s most prevalent and pressing health care needs by understanding and acting on what consumers want and need – personalized, people-centered care that treats them like a human being, not a number. From our innovative new services at HealthHUB™ locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable, and simply better.

Express Scripts, an Evernorth company, brings together powerful health services capabilities (Pharmacy+, Benefits Management+, Care+ and Intelligence+) to create life-changing solutions and unlock new potential. Empowered by our legacy as an industry innovator, we dare to imagine, and deliver, a better health care system, working with our partners to improve health outcomes and lower costs. From pharmacy and medical benefits management, to specialty pharmacy care and everything in between, we uncover opportunities to make health care work better. We stand alongside our clients and partners, collaborating to develop personalized solutions that make a meaningful difference in the lives of those we serve.

The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research organization dedicated to advancing fair pricing, fair access, and future innovation in health care. Using an evidence-based approach and deliberation in an open, public forum, ICER evaluates the benefits, harms, and value of novel prescription drugs in the U.S. The Midwest CEPAC is an Advisory Board that brings together employers, state officials, Medicaid leaders, private insurers, clinical and other policy leaders to discuss how to leverage the results of comparative effectiveness research to improve the quality and value of care delivered in the region.